Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2025 Earnings Call Transcript November 6, 2025
Iovance Biotherapeutics, Inc. beats earnings expectations. Reported EPS is $-0.25067, expectations were $-0.29.
Operator: Welcome to the Iovance Biotherapeutics Third Quarter and Year-to-Date 2025 Conference Call. My name is Daniel, and I will be your operator for today’s call. [Operator Instructions] Please note that this conference call is being recorded. I will now turn the call over to Sara...
